AU1018801A - Use of 3,4-substituted piperidines - Google Patents

Use of 3,4-substituted piperidines

Info

Publication number
AU1018801A
AU1018801A AU10188/01A AU1018801A AU1018801A AU 1018801 A AU1018801 A AU 1018801A AU 10188/01 A AU10188/01 A AU 10188/01A AU 1018801 A AU1018801 A AU 1018801A AU 1018801 A AU1018801 A AU 1018801A
Authority
AU
Australia
Prior art keywords
substituted piperidines
piperidines
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10188/01A
Inventor
Rolf Hohlweg
Christian Thomsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1018801A publication Critical patent/AU1018801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
AU10188/01A 1999-10-29 2000-10-26 Use of 3,4-substituted piperidines Abandoned AU1018801A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
DKPA199901558 1999-10-29
DKPA199901557 1999-10-29
DKPA199901556 1999-10-29
DKPA199901553 1999-10-29
DKPA199901555 1999-10-29
DKPA199901556 1999-10-29
DKPA199901557 1999-10-29
DKPA199901558 1999-10-29
DKPA199901554 1999-10-29
DKPA199901553 1999-10-29
DKPA199901555 1999-10-29
DKPA199901554 1999-10-29
DKPA200000159 2000-01-31
DKPA200000159 2000-01-31
PCT/DK2000/000595 WO2001032178A1 (en) 1999-10-29 2000-10-26 Use of 3,4-substituted piperidines

Publications (1)

Publication Number Publication Date
AU1018801A true AU1018801A (en) 2001-05-14

Family

ID=27561810

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10188/01A Abandoned AU1018801A (en) 1999-10-29 2000-10-26 Use of 3,4-substituted piperidines

Country Status (2)

Country Link
AU (1) AU1018801A (en)
WO (1) WO2001032178A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
JP2004509103A (en) * 2000-09-11 2004-03-25 セプレイコー　インコーポレイテッド Monoamine receptor and transporter ligands and methods of use
JP2005500371A (en) * 2001-08-08 2005-01-06 ニューロサーチ、アクティーゼルスカブ Substituted amine derivatives and methods of using them as monoamine neurotransmitter reuptake inhibitors
ITMI20031349A1 (en) * 2003-07-01 2005-01-02 Ufpeptides S R L ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
CN108025002B (en) * 2015-09-02 2022-05-13 特维娜有限公司 Delta opioid receptor modulating compounds containing six membered azaheterocycles, methods of use and preparation thereof
KR20190117658A (en) 2017-02-17 2019-10-16 트레베나, 인코포레이티드. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, and methods of using and preparing the same
BR112019016827A2 (en) 2017-02-17 2020-04-07 Trevena Inc 5-membered azaheterocyclic delta-opioid receptor modulating compounds, methods of use and production thereof
KR20200131845A (en) * 2018-03-13 2020-11-24 주빌런트 프로델 엘엘씨 Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK231088D0 (en) * 1988-04-28 1988-04-28 Ferrosan As PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
DE69525847T2 (en) * 1994-09-19 2002-09-05 Du Pont Pharm Co COMPOSITIONS OF OPIOID ANTAGONISTS WITH SELECTIVE SEROTONIN INHIBITORS, FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCY
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
WO1996029074A1 (en) * 1995-03-22 1996-09-26 Eli Lilly And Company Methods of treating or preventing pain or nociception
BR9608471A (en) * 1995-05-17 1998-12-29 Novo Nordisk As Process for the preparation of a compound
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
WO1998047514A1 (en) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Use of an nk-1 receptor antagonist and an ssri for treating obesity

Also Published As

Publication number Publication date
WO2001032178A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU2942000A (en) Novel piperidine derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002360561A1 (en) 4-substituted piperidines, and methods of use thereof
AU4318000A (en) Agarobiose-containing composition
AU6281100A (en) Novel diketopiperazines
AU1290501A (en) Composition
AU2001280135A1 (en) Fibrinogen lowering agents
AU5429000A (en) Novel bicyclonucleoside derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU1018801A (en) Use of 3,4-substituted piperidines
AU3676000A (en) 4-hydroxypiperidine derivatives having antiarrhythmic effect
IL132862A0 (en) New 4-substituted piperidines
AU1573100A (en) Composition of paroxetine methanesulfonate
IL148032A0 (en) 1,4-substituted 4,4-diaryl cyclohexanes
AU2673201A (en) Alpha-arylethylpiperazine derivatives as neurokinin antagonists
AU7963300A (en) Novel bipyridyl derivatives
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU4994400A (en) Novel quaternary compounds, compositions containing them, and uses thereof
AU6277699A (en) Guarantee 20
AU7557000A (en) Piperidine derivatives
AU2002214975A1 (en) Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
AU6310600A (en) Composition
AU3836600A (en) N-substituted piperidine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase